MTOR and metabolic dysfunction-associated steatohepatitis: The significance of perturbations to protein species in NASH livers was further examined in HepG2 cell cultures treated with various small-molecule kinase inhibitors targeting the PI3K/Akt/mTOR signaling pathway, which is an important regulator of cell cycle, protein biosynthesis, and autophagy33 (Fig. 5a).